BioSig Technologies Inc (BSGM) has released an update to notify the public and investors about a regulation fd disclosure.
BioSig Technologies, Inc. recently announced a significant milestone, with physicians successfully completing over 100 cases using the company’s Near Field Tracking algorithm. This development could be of interest to investors and market watchers, as it reflects the company’s progress in its field. However, BioSig has clarified that it will not update or amend the information regarding this achievement, and it should not be considered legally filed or as bearing any material obligation under federal securities laws.
For further insights into BSGM stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
